Progress in diagnosis and treatment of mixed subtype thyroid cancer
10.3760/cma.j.issn.115807-20200228-00049
- VernacularTitle:混合性甲状腺癌的诊治进展
- Author:
Zheng WAN
1
;
Mei LIU
;
Hongqing XI
;
Wen TIAN
Author Information
1. 中国人民解放军总医院第一医学中心普外科，北京 100853
- From:Chinese Journal of Endocrine Surgery
2020;14(4):338-342
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, with the rising incidence of thyroid cancer and the improvement of medical standards, the pathological types of thyroid cancer have been refined and improved. It is found in clinical work that a small number of patients’ tumors are not limited to a single pathological type, but that two or more pathological subtypes of the same patient are mixed together. This type is called mixed subtype thyroid cancer (MSTC) , whose cytology is diverse and complex, is highly dependent on the results of postoperative pathological examination. At present, there are few studies on MSTC diagnostic criteria, auxiliary examinations and treatment options. Therefore, the case characteristics and clinical diagnosis and treatment of this subtype of thyroid cancer are a new direction of exploration. This article reviews study of MSTC from the aspects of definition, disease characteristics, and auxiliary examinations, and explores the progress of MSTC diagnosis and treatment research, providing a new perspective for the clinical diagnosis and treatment of this type of disease for clinical reference.
